In the real-world setting, treatment adherence in patients with autosomal dominant polycystic kidney disease (ADPKD) can be a challenge. This CME program will discuss the diagnosis and management of ADPKD as well as strategies on improving treatment adherence. Patients perspectives on how to deal with aquaresis-related symptoms will be shared.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://p2psyncro.com/
- Start Date: 2024-06-30 05:00:00
- End Date: 2024-06-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) - Amount: 89500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest